Skip to main content
Thoth
Open Book Publishers

  1. The Antimicrobial Activity of Medicinal Maggots

Export Metadata

Metadata
Title
  1. The Antimicrobial Activity of Medicinal Maggots
ContributorYamni Nigam(author)
Michael R. Wilson(author)
DOIhttps://doi.org/10.11647/obp.0300.09
Landing pagehttps://www.openbookpublishers.com/books/10.11647/obp.0300/chapters/10.11647/obp.0300.09
Licensehttps://creativecommons.org/licenses/by-nc/4.0/
CopyrightYamni Nigam; Michael R. Wilson
PublisherOpen Book Publishers
Publication placeCambridge, UK
Published on2022-07-20
Long abstract
Page rangepp. 153–174
LanguageEnglish (Original)

Contributors

Yamni Nigam

(author)
Professor in Biomedical Sciences at Swansea University

Michael R. Wilson

(author)

References

  1. 1. Edwards, R. and K.G. Harding, Bacteria and Wound Healing. Current Opinion in Infectious Diseases, 2004. 17(2): pp. 91–96, https://doi.org/10.1097/00001432-200404000-00004. (opens in new tab)
  2. 2. Baer, W.S., The Treatment of Chronic Osteomyelitis with the Maggot (Larva of the Blow Fly). The Journal of Bone & Joint Surgery, 1931. 13(3): pp. 438–475, https://doi.org/10.1007/s11999-010-1416-3. (opens in new tab)
  3. 3. Harvey, M., The Natural History of Medicinal Flies, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 121–142, https://doi.org/10.11647/OBP.0300.07.(opens in new tab)
  4. 4. Duncan, J.T., On a Bactericidal Principle Present in the Alimentary Canal of Insects and Arachnids. Parasitology, 1926. 18(2): pp. 238–252, https://dx.doi.org/10.1017/S0031182000005205. (opens in new tab)
  5. 5. Robinson, W. and V.H. Norwood, The Role of Surgical Maggots in the Disinfection of Osteomyelitis and Other Infected Wounds. The Journal of Bone & Joint Surgery, 1933. 15(2): pp. 409–412.
  6. 6. Robinson, W. and V.H. Norwood, Destruction of Pyogenic Bacteria in the Alimentary Tract of Surgical Maggots Implanted in Infected Wounds. Journal of Laboratory and Clinical Medicine, 1934. 19(6): pp. 581–586.
  7. 7. Simmons, S.W., A Bactericidal Principle in Excretions of Surgical Maggots Which Destroys Important Etiological Agents of Pyogenic Infections. Journal of Bacteriology, 1935. 30(3): pp. 253–267, https://doi.org/10.1128/jb.30.3.253-267.1935. (opens in new tab)
  8. 8. Simmons, S.W., The Bactericidal Properties of Excretions of the Maggot of Lucilia sericata. Bulletin of Entomological Research, 1935. 26(4): pp. 559–563, https://doi.org/10.1017/S0007485300036907. (opens in new tab)
  9. 9. Pavillard, E.R. and E.A. Wright, An Antibiotic from Maggots. Nature, 1957. 180: pp. 916–917, https://doi.org/10.1038/180916b0.(opens in new tab)
  10. 10. Pöppel, A., et al., Antimicrobial Peptides Expressed in Medicinal Maggots of the Blow Fly Lucilia sericata Show Combinatorial Activity against Bacteria. Antimicrobial Agents and Chemotherapy, 2015. 59(5): pp. 2508–2514, https://doi.org/10.1128/AAC.05180-14. (opens in new tab)
  11. 11. Thomas, S., et al., The Anti-microbial Activity of Maggot Secretions: Results of a Preliminary Study. Journal of Tissue Viability, 1999. 9(4): pp. 127–132, https://doi.org/10.1016/S0965-206X(99)80032-1. (opens in new tab)
  12. 12. Bexfield, A., et al., Detection and Partial Characterisation of Two Antibacterial Factors from the Excretions/Secretions of the Medicinal Maggot Lucilia sericata and Their Activity against Methicillin-resistant Staphylococcus aureus (MRSA). Microbes and Infection, 2004. 6(14): pp. 1297–1304, https://doi.org/10.1016/j.micinf.2004.08.011. (opens in new tab)
  13. 13. Daeschlein, G., et al., In vitro Antibacterial Activity of Lucilia sericata Maggot Secretions. Skin Pharmacology and Physiology, 2007. 20(2): pp. 112–115, https://doi.org/10.1159/000097983. (opens in new tab)
  14. 14. Huberman, L., et al., Antibacterial Properties of Whole Body Extracts and Haemolymph of Lucilia sericata Maggots. Journal of Wound Care, 2007. 16(3): pp. 123–127, https://doi.org/10.12968/jowc.2007.16.3.27011. (opens in new tab)
  15. 15. Kerridge, A., H. Lappin-Scott, and J.R. Stevens, Antibacterial Properties of Larval Secretions of the Blowfly, Lucilia sericata. Medical and Veterinary Entomology, 2005. 19(3): pp. 333–337, https://doi.org/10.1111/j.1365-2915.2005.00577.x. (opens in new tab)
  16. 16. Jaklič, D., et al., Selective Antimicrobial Activity of Maggots against Pathogenic Bacteria. Journal of Medical Microbiology, 2008. 57(5): pp. 617–625, https://doi.org/10.1099/jmm.0.47515-0. (opens in new tab)
  17. 17. Steenvoorde, P. and G.N. Jukema, The Antimicrobial Activity of Maggots: In-vivo Results. Journal of Tissue Viability, 2004. 14(3): pp. 97–101, https://doi.org/10.1016/S0965-206X(04)43005-8. (opens in new tab)
  18. 18. Andersen, A.S., et al., Quorum-sensing-regulated Virulence Factors in Pseudomonas aeruginosa Are Toxic to Lucilia sericata Maggots. Microbiology, 2010. 156(2): pp. 400–407, https://doi.org/10.1099/mic.0.032730-0. (opens in new tab)
  19. 19. Barnes, K.M., R.A. Dixon, and D.E. Gennard, The Antibacterial Potency of the Medicinal Maggot, Lucilia sericata (Meigen): Variation in Laboratory Evaluation. Journal of Microbiological Methods, 2010. 82(3): pp. 234–237, https://doi.org/10.1016/j.mimet.2010.06.005. (opens in new tab)
  20. 20. Barnes, K.M., D.E. Gennard, and R.A. Dixon, An Assessment of the Antibacterial Activity in Larval Excretion/Secretion of Four Species of Insects Recorded in Association with Corpses, Using Lucilia sericata Meigen as the Marker Species. Bulletin of Entomological Research, 2010. 100(6): pp. 635–640, https://doi.org/10.1017/S000748530999071X. (opens in new tab)
  21. 21. Mumcuoglu, K.Y., et al., Destruction of Bacteria in the Digestive Tract of the Maggot of Lucilia sericata (Diptera: Calliphoridae). Journal of Medical Entomology, 2001. 38(2): pp. 161–166, https://doi.org/10.1603/0022-2585-38.2.161. (opens in new tab)
  22. 22. Malekian, A., et al., Efficacy of Maggot Therapy on Staphylococcus aureus and Pseudomonas aeruginosa in Diabetic Foot Ulcers. Journal of Wound, Ostomy and Continence Nursing, 2019. 46(1): pp. 25–29, https://doi.org/10.1097/WON.0000000000000496. (opens in new tab)
  23. 23. Borkataki, S., et al., Therapeutic Use of Lucilia sericata Maggot in Controlling Bacterial Bio-burden in Rat Wound Model. Tropical Biomedicine, 2018. 35(3): pp. 627–638.
  24. 24. Cazander, G., et al., Multiple Actions of Lucilia sericata Larvae in Hard-to-heal Wounds: Larval Secretions Contain Molecules that Accelerate Wound Healing, Reduce Chronic Inflammation and Inhibit Bacterial Infection. BioEssays, 2013. 35(12): pp. 1083–1092, https://doi.org/10.1002/bies.201300071. (opens in new tab)
  25. 25. Altincicek, B. and A. Vilcinskas, Septic Injury-inducible Genes in Medicinal Maggots of the Green Blow Fly Lucilia sericata. Insect Molecular Biology, 2009. 18(1): pp. 119–125, https://doi.org/10.1111/j.1365-2583.2008.00856.x. (opens in new tab)
  26. 26. Kawabata, T., et al., Induction of Antibacterial Activity in Larvae of the Blowfly Lucilia sericata by an Infected Environment. Medical and Veterinary Entomology, 2010. 24(4): pp. 375–381, https://doi.org/10.1111/j.1365-2915.2010.00902.x. (opens in new tab)
  27. 27. Jiang, K.C., et al., Excretions/Secretions from Bacteria-pretreated Maggot Are More Effective against Pseudomonas aeruginosa Biofilms. PloS ONE, 2012. 7(11): pp. e49815-e49815, https://doi.org/10.1371/journal.pone.0049815. (opens in new tab)
  28. 28. Barnes, K.M. and D.E. Gennard, The Effect of Bacterially-dense Environments on the Development and Immune Defences of the Blowfly Lucilia sericata. Physiological Entomology, 2011. 36(1): pp. 96–100, https://doi.org/10.1111/j.1365-3032.2010.00759.x. (opens in new tab)
  29. 29. Valachová, I., et al., Expression of Lucifensin in Lucilia sericata Medicinal Maggots in Infected Environments. Cell and Tissue Research, 2013. 353(1): pp. 165–171, https://doi.org/10.1007/s00441-013-1626-6. (opens in new tab)
  30. 30. Bexfield, A., et al., The Antibacterial Activity against MRSA Strains and Other Bacteria of a <500 Da Fraction from Maggot Excretions/Secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes and Infection, 2008. 10(4): pp. 325–333, https://doi.org/10.1016/j.micinf.2007.12.011. (opens in new tab)
  31. 31. van der Plas, M.J.A., et al., Maggot Excretions/Secretions Are Differentially Effective against Biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 2008. 61(1): pp. 117–122, https://doi.org/10.1093/jac/dkm407. (opens in new tab)
  32. 32. Bexfield, A., et al. Antimicrobial Composition and a Method of Controlling Contamination and Infection Using Said Composition. 2010. https://patents.google.com/patent/US20100215765.
  33. 33. Nigam, Y., et al., The Physiology of Wound Healing by the Medicinal Maggot, Lucilia sericata, S.J. Simpson, Editor. 2010, Elsevier: London. pp. 39–81.
  34. 34. Huberman, L., et al., Antibacterial Substances of Low Molecular Weight Isolated from the Blowfly, Lucilia sericata. Medical and Veterinary Entomology, 2007. 21(2): pp. 127–131, https://doi.org/10.1111/j.1365-2915.2007.00668.x. (opens in new tab)
  35. 35. Čeřovský, V., et al., Lucifensin, the Long-sought Antimicrobial Factor of Medicinal Maggots of the Blowfly Lucilia sericata. Cellular and Molecular Life Sciences, 2010. 67(3): pp. 455–466, https://doi.org/10.1007/s00018-009-0194-0. (opens in new tab)
  36. 36. Andersen, A.S., et al., A Novel Approach to the Antimicrobial Activity of Maggot Debridement Therapy. Journal of Antimicrobial Chemotherapy, 2010. 65(8): pp. 1646–1654, https://doi.org/10.1093/jac/dkq165. (opens in new tab)
  37. 37. Čeřovský, V. and R. Bém, Lucifensins, the Insect Defensins of Biomedical Importance: The Story behind Maggot Therapy. Pharmaceuticals, 2014. 7(3): pp. 251–264, https://doi.org/10.3390/ph7030251. (opens in new tab)
  38. 38. Čeřovský, V., et al., Lucifensin, a Novel Insect Defensin of Medicinal Maggots: Synthesis and Structural Study. ChemBioChem, 2011. 12(9): pp. 1352–1361, https://doi.org/10.1002/cbic.201100066. (opens in new tab)
  39. 39. Nygaard, M.K.E., et al., The Insect Defensin Lucifensin from Lucilia sericata. Journal of Biomolecular NMR, 2012. 52(3): pp. 277–282, https://doi.org/10.1007/s10858-012-9608-7. (opens in new tab)
  40. 40. El Shazely, B., et al., Lucifensin II, a Defensin of Medicinal Maggots of the Blowfly Lucilia cuprina (Diptera: Calliphoridae). Journal of Medical Entomology, 2013. 50(3): pp. 571–578, https://doi.org/10.1603/ME12208. (opens in new tab)
  41. 41. Zhang, Z., et al., Activity of Antibacterial Protein from Maggots against Staphylococcus aureus in vitro and in vivo. International Journal of Molecular Medicine, 2013. 31(5): pp. 1159–1165, https://doi.org/10.3892/ijmm.2013.1291. (opens in new tab)
  42. 42. Téllez, G.A. and J.C. Castaño-Osorio, Expression and Purification of an Active Cecropin-like Recombinant Protein against Multidrug Resistance Escherichia coli. Protein Expression and Purification, 2014. 100: pp. 48–53, https://doi.org/10.1016/j.pep.2014.05.004. (opens in new tab)
  43. 43. Téllez, G.A., et al., Identification, Characterization, Immunolocalization, and Biological Activity of Lucilin Peptide. Acta Tropica, 2018. 185: pp. 318–326, https://doi.org/10.1016/j.actatropica.2018.06.003. (opens in new tab)
  44. 44. Hirsch, R., et al., Profiling Antimicrobial Peptides from the Medical Maggot Lucilia sericata as Potential Antibiotics for MDR Gram-negative Bacteria. Journal of Antimicrobial Chemotherapy, 2019. 74(1): pp. 96–107, https://doi.org/10.1093/jac/dky386. (opens in new tab)
  45. 45. Yan, L., et al., Pharmacological Properties of the Medical Maggot: A Novel Therapy Overview. Evidence-Based Complementary and Alternative Medicine, 2018. 2018: pp. 1–11, https://doi.org/10.1155/2018/4934890. (opens in new tab)
  46. 46. Donlan, R.M., Biofilms: Microbial Life on Surfaces. 2002, Centers for Disease Control and Prevention (CDC), pp. 881–890.
  47. 47. Wolcott, R.D., D.D. Rhoads, and S.E. Dowd, Biofilms and Chronic Wound Inflammation. 2008, MA Healthcare London, pp. 333–341.
  48. 48. Siddiqui, A.R. and J.M. Bernstein, Chronic Wound Infection: Facts and Controversies. Clinics in Dermatology, 2010. 28(5): pp. 519–526, https://doi.org/10.1016/j.clindermatol.2010.03.009. (opens in new tab)
  49. 49. Zhao, G., et al., Biofilms and Inflammation in Chronic Wounds. Advances in Wound Care, 2013. 2(7): pp. 389–399, https://doi.org/10.1089/wound.2012.0381. (opens in new tab)
  50. 50. Nguyen, D., et al., Active Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-limited Bacteria. Science, 2011. 334(6058): pp. 982–986, https://doi.org/10.1126/science.1211037. (opens in new tab)
  51. 51. Harrison-Balestra, C., et al., A Wound-isolated Pseudomonas aeruginosa Grows a Biofilm in vitro within 10 Hours and Is Visualized by Light Microscopy. Dermatologic Surgery, 2003. 29(6): pp. 631–635, https://doi.org/10.1046/j.1524-4725.2003.29146.x. (opens in new tab)
  52. 52. Pritchard, D.I. and Y. Nigam, Maximising the Secondary Beneficial Effects of Larval Debridement Therapy. Journal of Wound Care, 2013. 22(11): pp. 610–616, https://doi.org/10.12968/jowc.2013.22.11.610. (opens in new tab)
  53. 53. Høiby, N., et al., Antibiotic Resistance of Bacterial Biofilms. International Journal of Antimicrobial Agents, 2010. 35(4): pp. 322–332, https://doi.org/10.1016/j.ijantimicag.2009.12.011. (opens in new tab)
  54. 54. Bohova, J., et al., Selective Antibiofilm Effects of Lucilia sericata Larvae Secretions/Excretions against Wound Pathogens. Evidence-Based Complementary and Alternative Medicine, 2014. 2014: pp. 1–9, https://doi.org/10.1155/2014/857360. (opens in new tab)
  55. 55. Harris, L.G., et al., Disruption of Staphylococcus Epidermidis Biofilms by Medicinal Maggot Lucilia sericata Excretions/Secretions. International Journal of Artificial Organs, 2009. 32(9): pp. 555–564, https://doi.org/10.1177/039139880903200904. (opens in new tab)
  56. 56. Harris, L.G., et al., Lucilia sericata Chymotrypsin Disrupts Protein Adhesin-mediated Staphylococcal Biofilm Formation. Applied and Environmental Microbiology, 2013. 79(4): pp. 1393–1395, http://dx.doi.org/10.1128/AEM.03689-12. (opens in new tab)
  57. 57. Cazander, G., et al., Maggot Excretions Inhibit Biofilm Formation on Biomaterials. Clinical Orthopaedics and Related Research, 2010. 468(10): pp. 2789–2796, https://doi.org/10.1007/s11999-010-1309-5. (opens in new tab)
  58. 58. Cowan, L.J., et al., Chronic Wounds, Biofilms and Use of Medicinal Larvae. Ulcers, 2013. 2013(Article ID 487024): pp. 1–7, https://doi.org/10.1155/2013/487024. (opens in new tab)
  59. 59. Liu, J., et al., Antibacterial and Anti-biofilm Effects of Fatty Acids Extract of Dried Lucilia sericata Larvae against Staphylococcus aureus and Streptococcus pneumoniae in vitro. Natural Product Research, 2019. https://doi.org/10.1080/14786419.2019.1627353. (opens in new tab)
  60. 60. Pritchard, D.I. and A.P. Brown, Degradation of MSCRAMM Target Macromolecules in VLU Slough by Lucilia sericata Chymotrypsin 1 (ISP) Persists in the Presence of Tissue Gelatinase Activity. International Wound Journal, 2015. 12(4): pp. 414–421, https://doi.org/10.1111/iwj.12124. (opens in new tab)
  61. 61. Brown, A., et al., Blow Fly Lucilia sericata Nuclease Digests DNA Associated with Wound Slough/Eschar and with Pseudomonas aeruginosa Biofilm. Medical and Veterinary Entomology, 2012. 26(4): pp. 432–439, https://doi.org/10.1111/j.1365-2915.2012.01029.x. (opens in new tab)
  62. 62. van der Plas, M.J.A., et al., Combinations of Maggot Excretions/Secretions and Antibiotics Are Effective against Staphylococcus aureus Biofilms and the Bacteria Derived Therefrom. The Journal of Antimicrobial Chemotherapy, 2010. 65(5): pp. 917–923, https://doi.org/10.1093/jac/dkq042. (opens in new tab)
  63. 63. Arora, S., C. Baptista, and C.S. Lim, Maggot Metabolites and Their Combinatory Effects with Antibiotic on Staphylococcus aureus. Annals of Clinical Microbiology and Antimicrobials, 2011. 10(6): pp. 1–8, https://doi.org/10.1186/1476-0711-10-6. (opens in new tab)
  64. 64. Cazander, G., et al., Synergism between Maggot Excretions and Antibiotics. Wound Repair and Regeneration, 2010. 18(6): pp. 637–642, https://doi.org/10.1111/j.1524-475X.2010.00625.x. (opens in new tab)
  65. 65. Alnaimat, S.M., M. Wainwright, and S.H. Aladaileh, An Initial in vitro Investigation into the Potential Therapeutic Use of Lucilia sericata Maggot to Control Superficial Fungal Infections. Jordan Journal of Biological Sciences, 2013. 6(2): pp. 137–142, https://doi.org/10.12816/0000271. (opens in new tab)
  66. 66. Amer, M.S., et al., Antimicrobial and Antiviral Activity of Maggots Extracts of Lucilia sericata (Diptera: Calliphoridae). Egyptian Journal of Aquatic Biology and Fisheries, 2019. 23(4): pp. 51–64, https://doi.org/10.21608/ejabf.2019.52173. (opens in new tab)
  67. 67. Evans, R., E. Dudley, and Y. Nigam, Detection and Partial Characterization of Antifungal Bioactivity from the Secretions of the Medicinal Maggot, Lucilia sericata. Wound Repair and Regeneration, 2015. 23(3): pp. 361–368, https://doi.org/10.1111/wrr.12287. (opens in new tab)
  68. 68. Pöppel, A., et al., Lucimycin, an Antifungal Peptide from the Therapeutic Maggot of the Common Green Bottle Fly Lucilia sericata. Biological Chemistry, 2014. 395(6): pp. 649–656, https://doi.org/10.1515/hsz-2013-0263. (opens in new tab)
  69. 69. Bohac, M., et al., Maggot Therapy in Treatment of a Complex Hand Injury Complicated by Mycotic Infection. Bratislava Medical Journal, 2015. 116(11): pp. 671–673, https://doi.org/10.4149/BLL_2015_128.(opens in new tab)